Rheacell, AOP partner on stem cell therapy for epidermolysis bullosa
Rheacell and AOP Health are partnering to make stem cell therapies available for people with epidermolysis bullosa (EB) in Europe and elsewhere. “This partnership marks a significant milestone for Rheacell and the further development of our stem cell medication programs,” Christoph Ganss, MD, Rheacell’s CEO, said in…